Photographer Seeking Bay Area Subjects to Tell Story of ME

A Bay area-based photographer is seeking people with myalgic encephalomyelitis (ME) who are willing to share their stories and to be photographed for his new awareness raising initiative. 

Photographer Mark Tuschman’s work can be seen on his website, his book project on the lack of human rights for women and girls and through his recent project on immigration

A close family member of Mark’s has recently been diagnosed, and he is eager to lend his talent to help raise awareness for all people with ME and raise funds for research and treatments.

Currently, Tuschman is looking for individuals with ME in the SF Bay area who are interested in telling their stories. 

If you are interested in participating, please email Mark at: [email protected]

-Mark Tuschman. 650 867 6364

@mark_tuschman

http://immigrantsareUS.org  

http://tuschmanphoto.com

http://facesofcouragebook2015.com

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top